Bath & Body Works (NYSE:BBWI - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.12 by $0.14, FiscalAI reports. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The business had revenue of $1.58 billion for the quarter, compared to analysts' expectations of $1.55 billion. During the same period in the previous year, the business earned $0.37 earnings per share. Bath & Body Works updated its Q4 2026 guidance to 1.410-1.610 EPS and its FY 2026 guidance to 2.600-2.800 EPS.
Bath & Body Works Stock Performance
Shares of BBWI stock opened at $18.68 on Thursday. Bath & Body Works has a 1 year low of $14.27 and a 1 year high of $24.94. The business's fifty day moving average is $19.21 and its 200-day moving average is $19.78. The stock has a market cap of $3.77 billion, a PE ratio of 4.86, a price-to-earnings-growth ratio of 0.92 and a beta of 1.31.
Bath & Body Works Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, December 4th. Stockholders of record on Friday, November 20th will be given a dividend of $0.20 per share. The ex-dividend date is Friday, November 20th. This represents a $0.80 annualized dividend and a dividend yield of 4.3%. Bath & Body Works's dividend payout ratio (DPR) is 20.83%.
Analyst Upgrades and Downgrades
A number of equities analysts recently issued reports on the stock. JPMorgan Chase & Co. increased their target price on shares of Bath & Body Works from $22.00 to $24.00 and gave the company a "neutral" rating in a research report on Tuesday, August 18th. UBS Group boosted their price target on shares of Bath & Body Works from $17.00 to $22.00 and gave the stock a "neutral" rating in a research report on Friday, November 13th. BMO Capital Markets initiated coverage on shares of Bath & Body Works in a research report on Tuesday, September 8th. They set a "market perform" rating and a $20.00 price target on the stock. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Bath & Body Works in a research note on Tuesday, October 6th. Finally, Robert W. Baird decreased their price objective on shares of Bath & Body Works from $25.00 to $23.00 and set a "neutral" rating for the company in a report on Thursday, August 27th. Four analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $22.53.
Check Out Our Latest Report on Bath & Body Works
Recent Bath & Body Works Headlines
Investors following BBWI have been watching these headlines:
- Positive Sentiment: Adjusted third-quarter EPS was $0.26, versus the $0.12 consensus, and revenue of $1.58 billion topped the $1.55 billion estimate. The company also raised its full-year sales outlook and maintained adjusted EPS guidance of $2.60–$2.80, above the $2.56 consensus. Third-quarter results and outlook
- Positive Sentiment: BBWI authorized a new $500 million share-repurchase program, which could return capital to shareholders and provide support for the stock. Third-quarter results and outlook
- Negative Sentiment: Fourth-quarter adjusted EPS guidance of $1.41–$1.61 is below the $1.72 analyst consensus. Revenue guidance of $2.6–$2.7 billion also tops out at, but does not exceed, the $2.7 billion consensus, raising concern about the near-term outlook. Third-quarter results and outlook
About Bath & Body Works
(
Get Free Report)
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.